**Introduction:** Since 2012, MERS-CoV has caused up to 2,220 cases and 790 deaths in 27 countries with Saudi Arabia being the most affected country with ∼83.1% of the cases and ∼38.8% local death rate. Current serological assays such as microneutralization (MN), plaque reduction neutralization, immunofluorescence, protein microarray or pseudoparticle neutralization assays rely on handling of live MERS-CoV in high containment laboratories or need for expensive and special equipment and reagents and highly trained personnel which represent a technical hurdle for most laboratories in resource-limited MERS-CoV endemic countries. Here, we developed, compared and evaluated three different indirect ELISAs based on different MERS-CoV proteins.

**Materials and Methods:** MERS-CoV nucleocapsid protein (rN), spike (rS) ectodomain (amino acids 1-1297) and rS1 subunit (amino acids 1-725) proteins were expressed, purified and used for ELISA assay development. Assays were developed using checkerboard titration and finally validated with a total of 353 serum samples collected between 2014 and 2017 from high-risk groups (79 seropositive and 274 seronegative samples) in comparison with MN assay.

**Results:** Three different ELISAs were developed using MERS-CoV rN, rS1 and rS, and cut-off values were found to be 0.30 for rN-ELISA, 0.26 for rS1-ELISA, and 0.34 for rS-ELISA. Upon validation, both rS1 and rS ELISAs maintained high sensitivity and specificity (≥90%) across a wider range of OD values compared to rN-ELISA. Moreover, rS1- and rS-based ELISAs showed better agreement and correlation with MN assay in contrast to rN-ELISA.

**Conclusions:** Our data suggest that rS1-ELISA and/or rS-ELISA are more reliable than rN-ELISA as they showed higher sensitivity, specificity, agreement and correlation with MN assay. They could be used independently or in combination in large-scale and high-throughput seroepidemiological screening in MERS-CoV endemic regions as they do not require high containment laboratories and could be adapted easily by any lab.
